Skip to main content

Pharmakokinetik und -dynamik von Famotidin bei Patienten mit terminaler Niereninsuffizienz

  • Conference paper
Book cover Famotidin heute

Zusammenfassung

Bei Niereninsuffizienz besteht eine erhöhte Inzidenz für das Auftreten peptischer Ulzera und gastrointestinaler Blutungen, die z T.auf eine Magensäurehypersekretion, z T.auf eine Hyper- gastrinämie zurückgeführt werden (Goldstein et al. 1967; Ritz et al. 1971; Venkateswaran et al. 1972; Shepherd et al. 1973; Milito et al. 1983, 1985).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Brodde OE & Daul A (1984). Alpha- and beta-adrenoceptor changes in patients on maintenance hemodialysis. Contrib. Nephrol., 41, 99–107.

    PubMed  CAS  Google Scholar 

  2. Daul AE, Khalifa AM, Graven N & Brodde OE (1984). Impaired regulation of ß-adrenoceptors in patients on maintenance haemodialysis. Proc. Proc Eur Dial Transplant Assoc, 21, 178–183.

    Google Scholar 

  3. Garg DC, Weidler DJ & Eshelman FN (1983). Ranitidine bioavailability and kinetics in normal male subjects. Clin. Pharmacol. Ther., 33, 445–452.

    Article  PubMed  CAS  Google Scholar 

  4. Goldstein H, Murphy D, Sokol A & Rubini ME (1967). Gastric acid secretion in patients undergoing chronic dialysis. Arch. Intern. Med.,. 120, 645–653.

    Article  PubMed  CAS  Google Scholar 

  5. Halstenson CE, Abraham PA, Opsahl JA, Keane WF, Kovarik JM, Chremos AN & Matzke GR (1986). Disposition of famotidine (F) in renal insufficiency. Clin. Pharmacol. Ther., 39, 197.

    Google Scholar 

  6. Jones RH, Lewin MR & Parsons V (1979). Therapeutic effect of Cimetidine in patients undergoing haemodialysis. Brit. Med. J., 1, 650–652.

    Article  PubMed  CAS  Google Scholar 

  7. Knoben JE & Anderson PO (1983). In: Hand Book of Clinical Drug Data in 5th Edn, pp 36. Illinois. Drug intelligence Publications.

    Google Scholar 

  8. Kroemer H & Klotz U (1987). Pharmacokinetics of famotidine in man. Int. J. Clin. Pharmacol. Ther. Toxicol. 25, 458–463.

    CAS  Google Scholar 

  9. Mann JFE, Hausen M, Jacobs KH, Kutter A, Nagel W, Rascher W, Schick M, Sudhoff R & Ritz E (1984). Adrenergic responsiveness in experimental uremia. Contrib. Nephrol., 41, 108–112.

    PubMed  CAS  Google Scholar 

  10. Milito G, Taccone-Gallucci M, Brancaleone C, Nardi F, Fillingeri V, Cesca D & Casciani CU (1983). Assessment of the upper gastrointestinal tract hemodialysis patients awaiting renal transplantation. Am J Gastroenterol. 78, 328–331.

    PubMed  CAS  Google Scholar 

  11. Milito G, Taccone-Gallucci M, Brancaleone C, Nardi F, Cesca D, Boffo V & Casciani CU (1985). The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int., 28, suppl. 17, S - 157 - 160

    Google Scholar 

  12. Peck CC & Barrett BB (1979). Nonlinear Least-Squares Regression Programs for micro-computers. J Pharmacokinet Biopharm., 5, 537 - 541

    Article  Google Scholar 

  13. Ritz E, Krempien B, Wanke M, Ziegler M, Wesch G & Torner U (1971). Klinische und experimentelle Untersuchungen zur urämischen Gastritis. Verh. Dtsch. Ges. Inn. Med., 77, 220 - 224

    PubMed  CAS  Google Scholar 

  14. Schäfer U, Stiller S & Mann H (1986). Measurement of solute balance during dialysis therapy, Life support Systems - Abstracts XIII. Annual Meeting Europ. Soc. Artif. Organs, Avigon, pp 237 - 239

    Google Scholar 

  15. Shepherd, AMM, Stewart WK & Wormsley KG (1973). Peptic ulceration in chronic renal failure. Lancet., 1, 1357 - 1359

    Article  PubMed  CAS  Google Scholar 

  16. Sica DA, Comstock T, Harford A & Eshelman F (1987). Ranitidine pharmacokinetics in continuous ambulatory peritoneal dialysis. Eur. J. Clin. Pharmacol., 32, 587 - 591

    Article  PubMed  CAS  Google Scholar 

  17. Smith JL, Gamal MA, Chremos AN & Graham DY (1985). Famotidine, a new H2-receptor antagonist: effect on parietal, nonparietal and pepsin secretion in man. Dig Dis Sei, 30, 308 - 312

    Article  CAS  Google Scholar 

  18. Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Saburo N, Shioki Y, Kawabata M, Hashimoto N & Hattori N (1983). Pharmacokinetics of famotidine in patients with renal insufficiency. Med Consultation, New Remedies., 20, 2061 - 2068

    Google Scholar 

  19. Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N & Hattori N (1985). Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function. Eur. J. Clin. Pharmacol. 28, 327 - 331

    Article  PubMed  CAS  Google Scholar 

  20. Takabatake T, Ohta H, Yamamoto Y, Ishida Y, Hara H, Nakamura S, Ushiogi Y, Kawabata M, Hashimoto N, Satoh S, Sasaki T, Yamada Y, Ohta K & Hattori N (1986). Pharmacokinetics and dosage requirements of famotidine: a new H2-receptor antagonist, in renal failure. Dig Dis Sei 31, (Suppl), 274 S.

    Google Scholar 

  21. Venkateswaran PS, Jeffers A & Hocken AG (1972). Gastric acid secretion in chronic renal failure. Brit. Med. J., 4, 22 - 23

    Article  Google Scholar 

  22. Wagner JG (1975). Linear compartment models. In Fundamentals of Clinical Pharmacokinetics, pp 57 - 128, Illinois, Drug Int. Pub

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gladziwa, U., Klotz, U., Krishna, D.R., Schmitt, H., Glöckner, W.M., Mann, H. (1989). Pharmakokinetik und -dynamik von Famotidin bei Patienten mit terminaler Niereninsuffizienz. In: Famotidin heute. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73807-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73807-4_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73808-1

  • Online ISBN: 978-3-642-73807-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics